Lv6
2140 积分 2023-12-04 加入
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
3天前
已完结
肝细胞癌靶向药物及免疫检查点抑制剂相关肝损伤管理共识（2024年版）
1个月前
已完结
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study
1个月前
已完结
肝细胞癌术后辅助治疗专家共识（2026版）
2个月前
已完结
Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options
2个月前
已完结
Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant
2个月前
已完结
Immunotherapy before liver transplant in unresectable hepatocellular carcinoma: a case report
2个月前
已完结
Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma
2个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
3个月前
已完结
Ipilimumab/nivolumab Myeloperoxidase anti-cytoplasmic neutrophilic antibody positive glomerulonephritis: case report
3个月前
已完结
皖公网安备34019202002308
